Lev DC - Search Results

1

Editor's Note: Inhibition of Platelet-derived Growth Factor-mediated Proliferation of Osteosarcoma Cells by the Novel Tyrosine Kinase Inhibitor STI571.

McGary EC, Weber K, Mills L, Doucet M, Lewis V, Lev DC, Fidler IJ, Bar-Eli M. McGary EC, et al. Among authors: lev dc. Clin Cancer Res. 2019 May 15;25(10):3196. doi: 10.1158/1078-0432.CCR-19-1101. Clin Cancer Res. 2019. PMID: 31092620 No abstract available.

2

Inhibition of platelet-derived growth factor-mediated proliferation of osteosarcoma cells by the novel tyrosine kinase inhibitor STI571.

McGary EC, Weber K, Mills L, Doucet M, Lewis V, Lev DC, Fidler IJ, Bar-Eli M. McGary EC, et al. Among authors: lev dc. Clin Cancer Res. 2002 Nov;8(11):3584-91. Clin Cancer Res. 2002. PMID: 12429650

3

Cellular adhesion pathways and metastatic potential of human melanoma.

McGary EC, Lev DC, Bar-Eli M. McGary EC, et al. Among authors: lev dc. Cancer Biol Ther. 2002 Sep-Oct;1(5):459-65. doi: 10.4161/cbt.1.5.158. Cancer Biol Ther. 2002. PMID: 12496470 Free article. Review.

4

Dacarbazine causes transcriptional up-regulation of interleukin 8 and vascular endothelial growth factor in melanoma cells: a possible escape mechanism from chemotherapy.

Lev DC, Ruiz M, Mills L, McGary EC, Price JE, Bar-Eli M. Lev DC, et al. Mol Cancer Ther. 2003 Aug;2(8):753-63. Mol Cancer Ther. 2003. PMID: 12939465

5

A fully human antimelanoma cellular adhesion molecule/MUC18 antibody inhibits spontaneous pulmonary metastasis of osteosarcoma cells in vivo.

McGary EC, Heimberger A, Mills L, Weber K, Thomas GW, Shtivelband M, Lev DC, Bar-Eli M. McGary EC, et al. Among authors: lev dc. Clin Cancer Res. 2003 Dec 15;9(17):6560-6. Clin Cancer Res. 2003. PMID: 14695161

6

Exposure of melanoma cells to dacarbazine results in enhanced tumor growth and metastasis in vivo.

Lev DC, Onn A, Melinkova VO, Miller C, Stone V, Ruiz M, McGary EC, Ananthaswamy HN, Price JE, Bar-Eli M. Lev DC, et al. J Clin Oncol. 2004 Jun 1;22(11):2092-100. doi: 10.1200/JCO.2004.11.070. Epub 2004 May 3. J Clin Oncol. 2004. PMID: 15123733

7

Inhibition of platelet-derived growth factor receptor signaling restricts the growth of human breast cancer in the bone of nude mice.

Lev DC, Kim SJ, Onn A, Stone V, Nam DH, Yazici S, Fidler IJ, Price JE. Lev DC, et al. Clin Cancer Res. 2005 Jan 1;11(1):306-14. Clin Cancer Res. 2005. PMID: 15671560

8

Platelet-activating factor mediates MMP-2 expression and activation via phosphorylation of cAMP-response element-binding protein and contributes to melanoma metastasis.

Melnikova VO, Mourad-Zeidan AA, Lev DC, Bar-Eli M. Melnikova VO, et al. Among authors: lev dc. J Biol Chem. 2006 Feb 3;281(5):2911-22. doi: 10.1074/jbc.M508683200. Epub 2005 Nov 23. J Biol Chem. 2006. PMID: 16306050 Free article.

9

ACTIBIND, a T2 RNase, competes with angiogenin and inhibits human melanoma growth, angiogenesis, and metastasis.

Schwartz B, Shoseyov O, Melnikova VO, McCarty M, Leslie M, Roiz L, Smirnoff P, Hu GF, Lev D, Bar-Eli M. Schwartz B, et al. Cancer Res. 2007 Jun 1;67(11):5258-66. doi: 10.1158/0008-5472.CAN-07-0129. Cancer Res. 2007. PMID: 17545605

10

Tumor immunotherapy in melanoma: strategies for overcoming mechanisms of resistance and escape.

Zigler M, Villares GJ, Lev DC, Melnikova VO, Bar-Eli M. Zigler M, et al. Among authors: lev dc. Am J Clin Dermatol. 2008;9(5):307-11. doi: 10.2165/00128071-200809050-00004. Am J Clin Dermatol. 2008. PMID: 18717605 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

169 results

Search Page

Filters